| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 7-Benzylidenenaltrexonemaleate Basic information |
| Product Name: | 7-Benzylidenenaltrexonemaleate | | Synonyms: | 7-benzylidene-7-dehydronaltrexonee;Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5α)-;BNTX;7-benzylidenenaltrexone | | CAS: | 129468-28-6 | | MF: | C27H27NO4 | | MW: | 429.52 | | EINECS: | | | Product Categories: | | | Mol File: | 129468-28-6.mol |  |
| | 7-Benzylidenenaltrexonemaleate Chemical Properties |
| Boiling point | 661.2±55.0 °C(Predicted) | | density | 1.43±0.1 g/cm3(Predicted) | | storage temp. | Desiccate at -20°C | | pka | 9.10±0.40(Predicted) |
| | 7-Benzylidenenaltrexonemaleate Usage And Synthesis |
| Uses | BNTX (7-Benzylidenenaltrexone) is a selective δ1-opioid receptor antagonist. BNTX antagonizes the antisecretory actions of DPDPE (HY-P1334), Deltorphin 2 (HY-P1013), and DAMGO (HY-P0210) competitively. BNTX can be used for research of antinociception[1]. | | Definition | ChEBI: (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-6-(phenylmethylene)-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one is a member of phenanthrenes. | | Biological Activity | Standard selective δ 1 opioid receptor antagonist. Also inhibits neurogenic ion transport mediated by a putative novel opioid receptor in porcine ileal mucosa. | | IC 50 | δ Opioid Receptor/DOR |
| | 7-Benzylidenenaltrexonemaleate Preparation Products And Raw materials |
|